Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
Xin Xu(Shanghai University of Sport), Liping Xie(First Affiliated Hospital Zhejiang University), Xianglai Xu(Fudan University), Zhenghui Hu(First Affiliated Hospital Zhejiang University), Hong Chen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yi Zhu(Jiangsu University), Jie Qin(Shanghai Medical College of Fudan University), Xiangyi Zheng(Tianjin University), Yeqing Mao(First Affiliated Hospital Zhejiang University), Jian Wu(Sun Yat-sen University)
Cited by 56
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells
|Cell and Tissue Research|2016|225